EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 63 filers reported holding EVELO BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11 | -92.7% | 58,418 | -37.7% | 0.00% | – |
| Q4 2022 | $151 | -100.0% | 93,841 | -49.2% | 0.00% | – |
| Q3 2022 | $386,000 | -5.4% | 184,663 | -4.4% | 0.00% | – |
| Q2 2022 | $408,000 | +175.7% | 193,134 | +343.7% | 0.00% | – |
| Q1 2022 | $148,000 | -87.2% | 43,529 | -77.1% | 0.00% | – |
| Q4 2021 | $1,152,000 | -50.7% | 189,757 | -42.8% | 0.00% | -100.0% |
| Q3 2021 | $2,336,000 | +236.6% | 331,906 | +556.7% | 0.00% | – |
| Q2 2021 | $694,000 | -48.0% | 50,538 | -59.5% | 0.00% | -100.0% |
| Q1 2021 | $1,335,000 | +177.0% | 124,808 | +212.8% | 0.00% | – |
| Q4 2020 | $482,000 | -39.9% | 39,902 | -73.8% | 0.00% | -100.0% |
| Q3 2020 | $802,000 | +536.5% | 152,140 | +491.6% | 0.00% | – |
| Q2 2020 | $126,000 | +193.0% | 25,715 | +125.1% | 0.00% | – |
| Q1 2020 | $43,000 | – | 11,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 479,242 | $6,585,000 | 7.28% |
| Flagship Pioneering Inc. | 23,030,069 | $316,433,000 | 4.04% |
| HARBOURVEST PARTNERS LLC | 3,063,505 | $42,093,000 | 4.02% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,564,000 | 2.31% |
| Alphabet Inc. | 1,060,495 | $14,571,000 | 0.30% |
| Artal Group S.A. | 1,000,000 | $13,740,000 | 0.28% |
| Larson Financial Group LLC | 31,354 | $431,000 | 0.10% |
| Virtus ETF Advisers LLC | 13,690 | $188,000 | 0.08% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 900,000 | $12,366,000 | 0.07% |
| CREDIT SUISSE AG/ | 3,095,719 | $42,536,000 | 0.02% |